JP2023134518A5 - - Google Patents
Info
- Publication number
- JP2023134518A5 JP2023134518A5 JP2023104610A JP2023104610A JP2023134518A5 JP 2023134518 A5 JP2023134518 A5 JP 2023134518A5 JP 2023104610 A JP2023104610 A JP 2023104610A JP 2023104610 A JP2023104610 A JP 2023104610A JP 2023134518 A5 JP2023134518 A5 JP 2023134518A5
- Authority
- JP
- Japan
- Prior art keywords
- methods
- substantially described
- novel products
- manufacturing methods
- manufacturing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662331993P | 2016-05-05 | 2016-05-05 | |
| US62/331,993 | 2016-05-05 | ||
| JP2018558225A JP7867321B2 (ja) | 2016-05-05 | 2017-05-04 | 透過性増強された医薬組成物 |
| PCT/US2017/031170 WO2017192923A1 (en) | 2016-05-05 | 2017-05-04 | Pharmaceutical compositions with enhanced permeation |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018558225A Division JP7867321B2 (ja) | 2016-05-05 | 2017-05-04 | 透過性増強された医薬組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023134518A JP2023134518A (ja) | 2023-09-27 |
| JP2023134518A5 true JP2023134518A5 (enExample) | 2026-05-13 |
Family
ID=58708068
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018558225A Active JP7867321B2 (ja) | 2016-05-05 | 2017-05-04 | 透過性増強された医薬組成物 |
| JP2023104610A Pending JP2023134518A (ja) | 2016-05-05 | 2023-06-27 | 透過性増強された医薬組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018558225A Active JP7867321B2 (ja) | 2016-05-05 | 2017-05-04 | 透過性増強された医薬組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20170290776A1 (enExample) |
| EP (1) | EP3452024A1 (enExample) |
| JP (2) | JP7867321B2 (enExample) |
| KR (1) | KR102536696B1 (enExample) |
| CN (2) | CN109310647A (enExample) |
| BR (1) | BR112018072467A2 (enExample) |
| CA (1) | CA3022797A1 (enExample) |
| IL (2) | IL262751B2 (enExample) |
| WO (1) | WO2017192923A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
| US12433850B2 (en) | 2016-05-05 | 2025-10-07 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine and prodrug compositions |
| CN122182527A (zh) | 2016-05-05 | 2026-06-12 | 阿奎斯蒂弗医疗股份有限公司 | 增强递送的肾上腺素组合物 |
| US12427121B2 (en) | 2016-05-05 | 2025-09-30 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
| US11007144B2 (en) | 2016-11-15 | 2021-05-18 | Klaria Pharma Holding Ab | Pharmaceutical formulation |
| EP3685868A1 (en) * | 2017-01-09 | 2020-07-29 | Verily Life Sciences LLC | Systems and methods for wearable emergency drug injection devices |
| GB201709141D0 (en) | 2017-06-08 | 2017-07-26 | Klaria Pharma Holding Ab | Pharmaceutical formulation |
| CN111465391A (zh) * | 2017-09-27 | 2020-07-28 | 阿奎斯蒂弗医疗股份有限公司 | 具有增强的递送的肾上腺素和前药的组合物 |
| JP7431724B2 (ja) * | 2017-09-27 | 2024-02-15 | アクエスティブ セラピューティクス インコーポレイテッド | 増強された透過を有する医薬組成物 |
| CN107903322B (zh) * | 2017-10-10 | 2022-03-08 | 宜宾学院 | 一种基于黄樟素环氧化改性制备抗菌胶原的方法 |
| GB201808462D0 (en) | 2018-05-23 | 2018-07-11 | Klaria Pharma Holding Ab | Pharmaceutical formulation |
| CA3105187A1 (en) | 2018-06-28 | 2020-01-02 | Arx, Llc | Dispensing method for producing dissolvable unit dose film constructs |
| WO2020051317A1 (en) * | 2018-09-07 | 2020-03-12 | Aquestive Therapeutics, Inc. | Oral film compositions and dosage forms having precise active dissolution profiles |
| MX2022004983A (es) * | 2019-11-01 | 2022-09-23 | Aquestive Therapeutics Inc | Composiciones de profarmaco y metodos de tratamiento. |
| CA3159389A1 (en) * | 2019-11-14 | 2021-05-20 | Aquestive Therapeutics, Inc. | Multimodal compositions comprising diazepam and methods of treatment |
| EP4072516A1 (en) | 2019-12-09 | 2022-10-19 | Nicoventures Trading Limited | Oral product comprising a cannabinoid |
| DE102020122557A1 (de) * | 2020-08-28 | 2022-03-03 | Lts Lohmann Therapie-Systeme Ag | Mucosa-Perforierung |
| WO2022074127A2 (en) * | 2020-10-08 | 2022-04-14 | Catalent U.K. Swindon Zydis Limited | Stable oral dispersible formulation for epinephrine and salts or solvates thereof |
| US11839602B2 (en) | 2020-11-25 | 2023-12-12 | Nicoventures Trading Limited | Oral cannabinoid product with lipid component |
| WO2023076281A1 (en) | 2021-10-25 | 2023-05-04 | Aquestive Therapeutics, Inc. | Oral and nasal compositions and methods of treatment |
| JP2025029732A (ja) | 2023-08-22 | 2025-03-07 | 三菱電機株式会社 | ゲート駆動装置 |
| CN120037250B (zh) * | 2025-04-07 | 2026-03-03 | 江苏知原药业股份有限公司 | 一种伊维菌素外用药物组合物、制备方法及应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1357891A (en) | 1920-07-15 | 1920-11-02 | Henry S Murray | Portable instantaneous water-heater |
| US20040265353A1 (en) * | 1995-07-28 | 2004-12-30 | Zars, Inc. | Systems and methods for treating panic attacks |
| US7425292B2 (en) | 2001-10-12 | 2008-09-16 | Monosol Rx, Llc | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| US7666337B2 (en) | 2002-04-11 | 2010-02-23 | Monosol Rx, Llc | Polyethylene oxide-based films and drug delivery systems made therefrom |
| US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
| US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| AU2003275855B2 (en) * | 2002-10-25 | 2009-04-23 | Paladin Labs (Barbados) Inc. | Sustained-release tramadol formulations with 24-hour efficacy |
| US20040096569A1 (en) * | 2002-11-15 | 2004-05-20 | Barkalow David G. | Edible film products and methods of making same |
| US20050266085A1 (en) * | 2004-05-28 | 2005-12-01 | Warner Kevin S | Gelled emulsion and microemulsion formulations for dermal drug delivery |
| US20070202163A1 (en) * | 2005-09-09 | 2007-08-30 | Mutasem Rawas-Qalaji | Fast-disintegrating epinephrine tablets for buccal or sublingual administration |
| IL175338A0 (en) * | 2006-05-01 | 2006-09-05 | Biota Ltd | Orally administrable films and preparation thereof |
| EP2457581B1 (en) * | 2009-07-23 | 2014-01-08 | Igisu Co., Ltd. | Composition comprising cnp or bnp for external preparation for skin for the treatment of dermatitis |
| US20120009261A1 (en) * | 2010-07-06 | 2012-01-12 | Grünenthal GmbH | Novel gastro-retentive dosage forms |
| CA2850952A1 (en) * | 2011-10-28 | 2013-05-02 | Sung-Yun Kwon | Dissolving solid solution perforator patch for migraine treatment |
| CN122182527A (zh) * | 2016-05-05 | 2026-06-12 | 阿奎斯蒂弗医疗股份有限公司 | 增强递送的肾上腺素组合物 |
-
2017
- 2017-05-04 EP EP17723617.1A patent/EP3452024A1/en active Pending
- 2017-05-04 BR BR112018072467-0A patent/BR112018072467A2/pt not_active Application Discontinuation
- 2017-05-04 JP JP2018558225A patent/JP7867321B2/ja active Active
- 2017-05-04 CN CN201780037588.XA patent/CN109310647A/zh active Pending
- 2017-05-04 US US15/587,376 patent/US20170290776A1/en not_active Abandoned
- 2017-05-04 KR KR1020187035236A patent/KR102536696B1/ko active Active
- 2017-05-04 WO PCT/US2017/031170 patent/WO2017192923A1/en not_active Ceased
- 2017-05-04 IL IL262751A patent/IL262751B2/en unknown
- 2017-05-04 CN CN202610234890.5A patent/CN122075448A/zh active Pending
- 2017-05-04 IL IL318880A patent/IL318880A/en unknown
- 2017-05-04 CA CA3022797A patent/CA3022797A1/en active Pending
-
2023
- 2023-06-27 JP JP2023104610A patent/JP2023134518A/ja active Pending